Results 191 to 196 of about 1,723 (196)

Establishing virtual bioequivalence and clinically relevant specifications using in vitro biorelevant dissolution testing and physiologically-based population pharmacokinetic modeling. case example: Naproxen

European Journal of Pharmaceutical Sciences, 2020
Ioannis Loisios-Konstantinidis, Rodrigo Cristofoletti, Nikoletta Fotaki   +2 more
exaly  

Biorelevant in vitro dissolution testing of products containing micronized or nanosized fenofibrate with a view to predicting plasma profiles

European Journal of Pharmaceutics and Biopharmaceutics, 2011
Ekarat Jantratid, Christos Reppas, Maria Vertzoni   +2 more
exaly  

Development and Application of a Biorelevant Dissolution Method Using USP Apparatus 4 in Early Phase Formulation Development

Molecular Pharmaceutics, 2010
Tawnya G Flick, Nina S Cauchon
exaly  

Dissolution and precipitation behavior of ternary solid dispersions of ezetimibe in biorelevant media

Drug Development and Industrial Pharmacy, 2017
Amani Alhayali, Sitaram P Velaga
exaly  

Investigation of dissolution behavior of diclofenac sodium extended release formulations under standard and biorelevant test conditions

Drug Development and Industrial Pharmacy, 2010
Grzegorz Garbacz, Werner Weitschies
exaly  

Biorelevant Dissolution Studies of Ezetimibe a BCS Class II Drug

2013
ORAN, U, BAYKA, ÇİĞDEM, TEKSİN, ZEYNEP ŞAFAK, ADIYAMAN, M   +3 more
openaire   +1 more source